In-silico evaluation of genetic alterations in ovarian carcinoma and therapeutic efficacy of nsc777201, as a novel multi-target agent for ttk, nek2, and cdk1
Dive into the research topics of 'In-silico evaluation of genetic alterations in ovarian carcinoma and therapeutic efficacy of nsc777201, as a novel multi-target agent for ttk, nek2, and cdk1'. Together they form a unique fingerprint.